+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In-Vitro Transcription Reagents Market - Global Forecast 2026-2032- Product Image
In-Vitro Transcription Reagents Market - Global Forecast 2026-2032- Product Image
Sale

In-Vitro Transcription Reagents Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6154000
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The In-Vitro Transcription Reagents Market is projected to reach USD 170.95 Million in 2026. It is expected to continue growing at a CAGR of 5.21%, reaching USD 231.12 Million by 2032.

In-Vitro Transcription Reagents: Executive Summary

In-vitro transcription reagents enable cell-free synthesis of RNA for research, molecular diagnostics, therapeutic development, vaccines, and synthetic biology. Demand is shaped by the need for consistent transcription performance, high-purity RNA, scalable workflows, and compatibility with increasingly automated laboratory platforms. The market includes enzymes, nucleotides, buffers, templates, reaction enhancers, and supporting purification components used across academic, clinical, biopharmaceutical, and industrial settings.

Workflow Integration Is Reshaping Reagent Selection

The landscape is shifting from standalone reagent purchases toward integrated, application-specific workflows. Users increasingly evaluate transcription yield, RNA integrity, impurity control, lot consistency, storage stability, and compatibility with downstream purification, formulation, sequencing, and delivery processes. Automation, standardized protocols, low-volume reactions, and demand for reproducible results are also encouraging suppliers and laboratories to prioritize ready-to-use formats and validated workflow components.

Artificial Intelligence Strengthens Design, Optimization, and Quality Control

Artificial intelligence is influencing in-vitro transcription through sequence design, promoter selection, reaction-condition optimization, process monitoring, and interpretation of quality-control data. Machine-learning tools can help identify sequence features associated with transcription efficiency or unwanted by-products, while automated experimentation can test reagent combinations more systematically. Adoption remains dependent on high-quality training data, transparent validation, laboratory integration, and safeguards against overreliance on models that have not been verified across templates, enzymes, and production conditions.

Regional Insights Across Research and Biomanufacturing Hubs

North America benefits from strong biotechnology research, translational development, advanced laboratory automation, and demand for high-performance RNA workflows. Europe combines established academic and pharmaceutical capabilities with rigorous quality expectations and cross-border research networks. Asia-Pacific is supported by expanding molecular biology infrastructure, vaccine and therapeutic research, and growing laboratory automation, particularly across major science and manufacturing centers. Latin America is developing capacity through academic, public-health, and biotechnology programs, although procurement conditions and technical infrastructure vary. The Middle East is strengthening research and biomanufacturing capabilities through strategic investment, while Africa’s opportunities are linked to improved laboratory access, local research capacity, public-health priorities, and technology-transfer initiatives.

Group Insights: Diverse Policy and Innovation Environments

ASEAN markets are building shared scientific capacity while navigating differences in regulation, procurement, and laboratory infrastructure. BRICS economies combine substantial research populations with varied domestic manufacturing, funding, and technology-access conditions. The European Union benefits from coordinated research activity and common regulatory structures, although implementation can differ among member states. G7 economies generally support advanced life-science research, quality systems, and automation. GCC countries are investing in biotechnology, diagnostics, and research infrastructure, with partnerships helping accelerate capability development. NATO members span mature and emerging biotechnology ecosystems, creating opportunities for interoperable research standards, resilient supply chains, and collaborative preparedness programs.

Country Insights: Capabilities Differ by Research Depth and Infrastructure

Australia supports genomics, biomedical research, and biomanufacturing initiatives across universities and specialized laboratories. Brazil and Mexico are expanding biotechnology and public-health research while addressing procurement and infrastructure variability. Canada combines strong academic science with translational and biopharmaceutical activity. China, India, Japan, and South Korea maintain broad research and manufacturing ecosystems, with increasing attention to domestic capability and advanced RNA applications. France, Germany, Italy, Spain, and the United Kingdom contribute established pharmaceutical, clinical, and academic networks, alongside demanding quality and compliance requirements. Russia retains scientific expertise but faces constraints related to international access, supply continuity, and collaboration. The United States remains a major center for biotechnology innovation, therapeutic research, automation, and high-throughput molecular workflows.

Priorities for Leaders: Build Reliable, Application-Ready Workflows

Industry leaders should segment products by use case, emphasizing validated performance for research, diagnostic, therapeutic, and manufacturing workflows rather than relying on generic specifications. They should strengthen lot-release testing, impurity characterization, documentation, cold-chain resilience, and technical support. Partnerships with automation providers, sequencing laboratories, therapeutic developers, and regional distributors can improve workflow adoption. Leaders should also deploy artificial intelligence selectively, using controlled validation, traceable data, human review, and continuous performance monitoring. Regional strategies should account for local procurement rules, technical skills, infrastructure, and the need for dependable supply continuity.

Research Methodology: Evidence-Based Market Assessment

This executive summary uses the defined in-vitro transcription reagents scope and synthesizes verified qualitative evidence on applications, workflow requirements, biotechnology infrastructure, regional conditions, and technology adoption. Analysis distinguishes reagent functionality from downstream products and avoids unsupported numerical claims. Regional, group, and country perspectives are developed by considering research capacity, biopharmaceutical activity, public-health priorities, laboratory infrastructure, regulatory context, supply-chain conditions, and adoption of automation and artificial intelligence. Findings should be interpreted as strategic context rather than market estimates or forecasts.

Conclusion: Reproducibility and Integration Will Define Advantage

In-vitro transcription reagents are becoming more closely connected to complete RNA-production workflows spanning discovery, diagnostics, therapeutics, and biomanufacturing. Competitive advantage will increasingly depend on reproducible performance, impurity control, automation compatibility, technical evidence, and resilient regional support. Organizations that combine dependable reagent quality with validated digital tools, application-focused service, and flexible supply strategies will be better positioned to respond to the evolving needs of research and industrial users.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. In-Vitro Transcription Reagents Market, by Product Type
7.1. Introduction
7.2. Buffers And Enzymes
7.2.1. Supplementary Enzymes
7.2.2. Transcription Buffers
7.3. Kits
7.3.1. Complete Transcription Kits
7.3.2. Custom Transcription Kits
7.4. Nucleotides
7.4.1. Modified Nucleotides
7.4.2. Standard Nucleotide Triphosphates
7.5. Rna Polymerase
7.5.1. SP6 Polymerase
7.5.2. T3 Polymerase
7.5.3. T7 Polymerase
8. In-Vitro Transcription Reagents Market, by Application
8.1. Introduction
8.2. Crispr
8.2.1. Gene Editing Research
8.2.2. Therapeutic Development
8.3. Gene Expression Analysis
8.3.1. Qrt-Pcr
8.3.2. Rna-Seq
8.4. Rna Interference
8.4.1. Shrna Synthesis
8.4.2. Sirna Synthesis
8.5. Vaccine Development
9. In-Vitro Transcription Reagents Market, by End User
9.1. Introduction
9.2. Academic And Research Institutes
9.2.1. Government Laboratories
9.2.2. Universities
9.3. Contract Research Organizations
9.4. Pharmaceutical And Biotechnology Companies
9.4.1. Large Pharma
9.4.2. Small Biotech
10. In-Vitro Transcription Reagents Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. In-Vitro Transcription Reagents Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. In-Vitro Transcription Reagents Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Agilent Technologies, Inc.
14.2. Bio-Rad Laboratories, Inc.
14.3. Genscript Biotech Corporation
14.4. Integrated DNA Technologies, Inc.
14.5. Lonza Group Ltd
14.6. Merck KGaA
14.7. Moderna, Inc.
14.8. New England Biolabs, Inc.
14.9. Promega Corporation
14.10. Qiagen N.V.
14.11. Roche Diagnostics GmbH
14.12. Takara Bio Inc.
14.13. Thermo Fisher Scientific Inc.
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global In-Vitro Transcription Reagents Market, Years Considered for the Study
FIGURE 2. Global In-Vitro Transcription Reagents Market, Research Design
FIGURE 3. Global In-Vitro Transcription Reagents Market, Research Framework
FIGURE 4. Global In-Vitro Transcription Reagents Market, Data Triangulation
FIGURE 5. Global In-Vitro Transcription Reagents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global In-Vitro Transcription Reagents Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global In-Vitro Transcription Reagents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global In-Vitro Transcription Reagents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global In-Vitro Transcription Reagents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global In-Vitro Transcription Reagents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global In-Vitro Transcription Reagents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global In-Vitro Transcription Reagents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global In-Vitro Transcription Reagents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global In-Vitro Transcription Reagents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global In-Vitro Transcription Reagents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global In-Vitro Transcription Reagents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global In-Vitro Transcription Reagents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global In-Vitro Transcription Reagents Market Segmentation & Coverage
TABLE 2. Global In-Vitro Transcription Reagents Market Size, 2017-2032 (USD Million)
TABLE 3. Global In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Buffers And Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Buffers And Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Buffers And Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Supplementary Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Supplementary Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Supplementary Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Transcription Buffers Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Transcription Buffers Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Transcription Buffers Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Complete Transcription Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Complete Transcription Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Complete Transcription Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Custom Transcription Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Custom Transcription Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Custom Transcription Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Nucleotides Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Nucleotides Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Nucleotides Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Modified Nucleotides Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Modified Nucleotides Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Modified Nucleotides Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Standard Nucleotide Triphosphates Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Standard Nucleotide Triphosphates Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Standard Nucleotide Triphosphates Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Rna Polymerase Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Rna Polymerase Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Rna Polymerase Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global SP6 Polymerase Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global SP6 Polymerase Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global SP6 Polymerase Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global T3 Polymerase Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global T3 Polymerase Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global T3 Polymerase Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global T7 Polymerase Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global T7 Polymerase Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global T7 Polymerase Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 44. Global Crispr Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Crispr Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Crispr Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Gene Editing Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Gene Editing Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Gene Editing Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Therapeutic Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Therapeutic Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Therapeutic Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Gene Expression Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Gene Expression Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Gene Expression Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Qrt-Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Qrt-Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Qrt-Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Rna-Seq Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Rna-Seq Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Rna-Seq Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Rna Interference Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Rna Interference Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Rna Interference Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Shrna Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Shrna Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Shrna Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Sirna Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Sirna Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Sirna Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Vaccine Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Vaccine Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Vaccine Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Government Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Government Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Government Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Universities Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Universities Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Universities Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Pharmaceutical And Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Pharmaceutical And Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Pharmaceutical And Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Large Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Large Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Large Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Small Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Small Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Small Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global In-Vitro Transcription Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 110. North America In-Vitro Transcription Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. North America In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. North America In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 113. North America In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 114. North America In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 115. North America In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 116. North America In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. North America In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 118. North America In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 119. North America In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 120. North America In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. North America In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 122. North America In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 123. Latin America In-Vitro Transcription Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Latin America In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. Latin America In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 126. Latin America In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 127. Latin America In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 128. Latin America In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 129. Latin America In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. Latin America In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 131. Latin America In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 132. Latin America In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 133. Latin America In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Latin America In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 135. Latin America In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 136. Europe In-Vitro Transcription Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Europe In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. Europe In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 139. Europe In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 140. Europe In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 141. Europe In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 142. Europe In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. Europe In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 144. Europe In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 145. Europe In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 146. Europe In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Europe In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 148. Europe In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 149. Middle East In-Vitro Transcription Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Middle East In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. Middle East In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 152. Middle East In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 153. Middle East In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 154. Middle East In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 155. Middle East In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Middle East In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 157. Middle East In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 158. Middle East In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 159. Middle East In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Middle East In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 161. Middle East In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 162. Africa In-Vitro Transcription Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Africa In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. Africa In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 165. Africa In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 166. Africa In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 167. Africa In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 168. Africa In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. Africa In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 170. Africa In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 171. Africa In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 172. Africa In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Africa In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 174. Africa In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 175. Global In-Vitro Transcription Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. ASEAN In-Vitro Transcription Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. ASEAN In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. ASEAN In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 179. ASEAN In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 180. ASEAN In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 181. ASEAN In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 182. ASEAN In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. ASEAN In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 184. ASEAN In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 185. ASEAN In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 186. ASEAN In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. ASEAN In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 188. ASEAN In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 189. GCC In-Vitro Transcription Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. GCC In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. GCC In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 192. GCC In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 193. GCC In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 194. GCC In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 195. GCC In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. GCC In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 197. GCC In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 198. GCC In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 199. GCC In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. GCC In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 201. GCC In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 202. European Union In-Vitro Transcription Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. European Union In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. European Union In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 205. European Union In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 206. European Union In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 207. European Union In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 208. European Union In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. European Union In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 210. European Union In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 211. European Union In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 212. European Union In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. European Union In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 214. European Union In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 215. BRICS In-Vitro Transcription Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. BRICS In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. BRICS In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 218. BRICS In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 219. BRICS In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 220. BRICS In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 221. BRICS In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. BRICS In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 223. BRICS In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 224. BRICS In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 225. BRICS In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. BRICS In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 227. BRICS In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 228. G7 In-Vitro Transcription Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. G7 In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. G7 In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 231. G7 In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 232. G7 In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 233. G7 In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 234. G7 In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. G7 In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 236. G7 In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 237. G7 In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 238. G7 In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. G7 In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 240. G7 In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 241. NATO In-Vitro Transcription Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. NATO In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 243. NATO In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 244. NATO In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 245. NATO In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 246. NATO In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 247. NATO In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. NATO In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 249. NATO In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 250. NATO In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 251. NATO In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. NATO In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 253. NATO In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 254. Global In-Vitro Transcription Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 255. United States In-Vitro Transcription Reagents Market Size, 2017-2032 (USD Million)
TABLE 256. United States In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 257. United States In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 258. United States In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 259. United States In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 260. United States In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 261. United States In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. United States In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 263. United States In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 264. United States In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 265. United States In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. United States In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 267. United States In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 268. Canada In-Vitro Transcription Reagents Market Size, 2017-2032 (USD Million)
TABLE 269. Canada In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. Canada In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 271. Canada In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 272. Canada In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 273. Canada In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 274. Canada In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. Canada In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 276. Canada In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 277. Canada In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 278. Canada In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Canada In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 280. Canada In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 281. Mexico In-Vitro Transcription Reagents Market Size, 2017-2032 (USD Million)
TABLE 282. Mexico In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 283. Mexico In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 284. Mexico In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 285. Mexico In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 286. Mexico In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 287. Mexico In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 288. Mexico In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 289. Mexico In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 290. Mexico In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 291. Mexico In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. Mexico In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 293. Mexico In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 294. Brazil In-Vitro Transcription Reagents Market Size, 2017-2032 (USD Million)
TABLE 295. Brazil In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 296. Brazil In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 297. Brazil In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 298. Brazil In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 299. Brazil In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 300. Brazil In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 301. Brazil In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 302. Brazil In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 303. Brazil In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 304. Brazil In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. Brazil In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 306. Brazil In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 307. United Kingdom In-Vitro Transcription Reagents Market Size, 2017-2032 (USD Million)
TABLE 308. United Kingdom In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 309. United Kingdom In-Vitro Transcription Reagents Market Size, by Buffers And Enzymes, 2017-2032 (USD Million)
TABLE 310. United Kingdom In-Vitro Transcription Reagents Market Size, by Kits, 2017-2032 (USD Million)
TABLE 311. United Kingdom In-Vitro Transcription Reagents Market Size, by Nucleotides, 2017-2032 (USD Million)
TABLE 312. United Kingdom In-Vitro Transcription Reagents Market Size, by Rna Polymerase, 2017-2032 (USD Million)
TABLE 313. United Kingdom In-Vitro Transcription Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 314. United Kingdom In-Vitro Transcription Reagents Market Size, by Crispr, 2017-2032 (USD Million)
TABLE 315. United Kingdom In-Vitro Transcription Reagents Market Size, by Gene Expression Analysis, 2017-2032 (USD Million)
TABLE 316. United Kingdom In-Vitro Transcription Reagents Market Size, by Rna Interference, 2017-2032 (USD Million)
TABLE 317. United Kingdom In-Vitro Transcription Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 318. United Kingdom In-Vitro Transcription Reagents Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 319. United Kingdom In-Vitro Transcription Reagents Market Size, by Pharmaceutical And Biotechnology Companies, 2017-2032 (USD Million)
TABLE 320. Germany In-Vitro Transcription Reagents Market Size, 2017-2032 (USD Million)
TABLE 321. Germany In-Vitro Transcription Reagents Market Size, by Product Type, 2017-2032

Companies Mentioned

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Genscript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • Lonza Group Ltd
  • Merck KGaA
  • Moderna, Inc.
  • New England Biolabs, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Roche Diagnostics GmbH
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

In-Vitro Transcription Templates Market Report 2026 - Product Image

In-Vitro Transcription Templates Market Report 2026

  • Report
  • 250 Pages
  • Global
From
In-vitro Transcription Templates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

In-vitro Transcription Templates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 70 Pages
  • Global
From
In-Vitro Transcription Templates - Global Strategic Business Report - Product Image

In-Vitro Transcription Templates - Global Strategic Business Report

  • Report
  • 242 Pages
  • Global
From
RNA Synthesis Market - Global Forecast 2026-2032 - Product Image

RNA Synthesis Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Report 2026 - Product Image

Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.